A new blood test that could change the way cancer is detected and diagnosed is soon to become available in the U.S.

The Galleri blood test was developed by GRAIL, a San Francisco, California-based biotechnology company.

The test is expected to be able to detect 50 different types of cancer via a blood test such as pancreatic, ovarian and esophageal.